Description

A patient receiving statin therapy may develop a myopathy that can be life-threatening. The risk may be increased if certain factors are present.


 

Risk factors for statin-associated myopathy:

(1) hepatic dysfunction

(2) renal dysfunction

(3) hypothyroidism

(4) diabetes mellitus

(5) drug interactions (see below)

(6) > 1 quart of grapefruit juice per day

(7) debilitation

(8) high statin dosage

(9) myotoxin or myotoxic drug

 

Drugs that may interact with statins to increase the risk for myopathy:

(1) fibrates (fibric acid derivatives), especially gemfibrozil

(2) niacin (nicotinic acid)

(3) cyclosporine

(4) azole antifungals

(5) macrolide antibiotics

(6) protease inhibitors (for HIV infection)

(7) nefazodone

(8) verapamil and diltiazem

(9) amiodarone

(10) warfarin

(11) digoxin

(12) mibefradil (a calcium channel blocker)

 

Mechanisms:

(1) increased plasma concentration of statins, often due to decreased metabolism by the CYP3A4 system.

(2) predisposition to or pre-existing muscle disease

 


To read more or access our algorithms and calculators, please log in or register.